- Home
- IFRX vs SFBC Comparison
IFRX vs SFBC Comparison
Compare IFRX & SFBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFRX
- SFBC
- Stock Information
- Founded
- IFRX 2007
- SFBC 1953
- Country
- IFRX Germany
- SFBC United States
- Employees
- IFRX N/A
- SFBC N/A
- Industry
- IFRX Biotechnology: Pharmaceutical Preparations
- SFBC Savings Institutions
- Sector
- IFRX Health Care
- SFBC Finance
- Exchange
- IFRX Nasdaq
- SFBC Nasdaq
- Market Cap
- IFRX 117.8M
- SFBC 127.6M
- IPO Year
- IFRX 2017
- SFBC N/A
- Fundamental
- Price
- IFRX $1.05
- SFBC $50.65
- Analyst Decision
- IFRX Strong Buy
- SFBC
- Analyst Count
- IFRX 2
- SFBC 0
- Target Price
- IFRX $9.00
- SFBC N/A
- AVG Volume (30 Days)
- IFRX 356.5K
- SFBC 2.0K
- Earning Date
- IFRX 03-20-2025
- SFBC 04-28-2025
- Dividend Yield
- IFRX N/A
- SFBC 1.51%
- EPS Growth
- IFRX N/A
- SFBC N/A
- EPS
- IFRX N/A
- SFBC 1.80
- Revenue
- IFRX $171,642.00
- SFBC $35,777,000.00
- Revenue This Year
- IFRX $381.73
- SFBC N/A
- Revenue Next Year
- IFRX $2,277.23
- SFBC N/A
- P/E Ratio
- IFRX N/A
- SFBC $27.86
- Revenue Growth
- IFRX 162.79
- SFBC N/A
- 52 Week Low
- IFRX $1.01
- SFBC $39.15
- 52 Week High
- IFRX $2.82
- SFBC $55.99
- Technical
- Relative Strength Index (RSI)
- IFRX 31.57
- SFBC 48.39
- Support Level
- IFRX $1.16
- SFBC $50.15
- Resistance Level
- IFRX $1.30
- SFBC $51.89
- Average True Range (ATR)
- IFRX 0.12
- SFBC 0.59
- MACD
- IFRX 0.02
- SFBC 0.03
- Stochastic Oscillator
- IFRX 9.76
- SFBC 44.86
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its lead product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
About SFBC Sound Financial Bancorp Inc.
Sound Financial Bancorp Inc operates as the holding company for Sound Community Bank that provides traditional banking and other financial services for individuals and businesses. It attracts retail and commercial deposits from the public and invests those funds, along with borrowed funds, in loans secured by first and second mortgages on one-to-four-family residences including home equity loans and lines of credit, commercial and multifamily real estate, construction and land, consumer and commercial business loans. The bank also offers secured and unsecured consumer loan products, including manufactured home loans, floating home loans, automobile loans, boat loans, and recreational vehicle loans.